Which biotech company’s shares have rocketed to a new high on good news?

Imricor Medical (ASX:IMR) FDA Approval Ignites Shares, but the Real Test Starts Now

FDA Approval Is a Big Win, Not the Finish Line Imricor Medical (ASX:IMR) received FDA clearance for its Vision-MR diagnostic catheter, marking the company’s first regulatory approval in the US and a significant milestone in its commercial journey. This approval enables Imricor to begin commercial rollout of the catheter, and the market responded positively, with…

Imricor Medical Systems runs hard on FDA greenlight for diagnostic catheter

Imricor Medical Systems (ASX:IMR) has won its first keystone FDA clearance Monday, with the United States health and drug regulator effectively thumbs-upping Imricor’s diagnostic catheter product, which takes electrophysiological data from the human heart during an MRI scan to effectively map a patient’s heart. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify,…

Which biotech company’s shares have rocketed to a new high on good news?

Shares in Imricor Medical Systems Inc (ASX: IMR) surged to a new 12-month high after the company announced it had secured a key approval in the US. Imricor shares traded as high as $1.99 on the news, up more than 25%, before settling back to be 16.5% higher at $1.84. The biotechnology company said in its statement to the ASX that the US Food and Drug Administration (FDA) had granted clearance for its Vision-MR Diagnostic Catheter, which would al…

Hot Stocks: Imricor Medical Systems, Brazilian Critical Minerals, Global Uranium and Enrichment

US equities closed last week at record highs after a softer-than-expected December jobs report reinforced confidence in a steady, but not overheating, economic expansion. The S&P 500 and Dow both set new record closes, while the Nasdaq also advanced strongly, capping solid weekly gains across all three indices. Payroll growth of 50,000 came in below expectations but was offset by a slight dip in the unemployment rate to 4.4%, supporting the view…